Using AI by ME/CFS patients is an increasing trend. This review in Forbes, ranked the best at just 62%, so beware! Which Is The Best AI For Medical Questions? Here’s The Winner

I am going to use microbiome data from the 1998 Alison Hunter Memorial Foundation conference on ME/CFS. The pattern reported is very common with sufferers of ME/CFS and Long COVID. I will use that report to phrase some questions. In theory, this is what could have been suggested by a progressive MD using AI in 1999. At the bottom are some comments from reviewing these responses. I have not mentioned the condition to the AI.

With a microbiome with decreased E.Coli (50% below normal), Bifidobacterium, Lactobacillus AND increased klebsiella/Enterobacter and Enterococcus how should a patient diet and supplements be changed?

With a microbiome with decreased E.Coli (50% below normal), Bifidobacterium, Lactobacillus AND increased klebsiella/Enterobacter and Enterococcus what prescription drugs be given?

Remember, with multiple answers from different experts:

• Go with what is most suggested
• Avoid any items where there is disagreement

Using Heidi (health AI)

Just go there and copy the above questions for full details including references.

• A high-fiber, plant-rich diet is the most evidence-supported single intervention — it creates SCFA production, lowers colonic pH, and suppresses Enterobacteriaceae overgrowth
• Prebiotics (inulin, FOS, GOS) selectively stimulate Bifidobacterium and Lactobacillus and attenuate Enterobacteriaceae blooms
• Multi-strain Bifidobacterium + Lactobacillus probiotics directly restore depleted commensals and competitively suppress pathobionts
• Berberine shows antimicrobial activity against Klebsiella and Enterococcus at gut-relevant concentrations but caution is warranted as it may paradoxically increase Enterococcus in some contexts
• Avoid refined carbohydrates, simple sugars, and ultra-processed foods — these preferentially fuel Enterobacteriaceae and Enterococcus growth
• Importantly, note that the low E. coli finding is likely a relative reflection of the Enterobacteriaceae dysbiosis, not an independent deficiency requiring specific treatment

Prescription

Perplexity

Goal	What to do	Why
Starve Klebsiella/Enterobacter	Low-starch diet: avoid potatoes, white rice, wheat/barley/rye, corn, pasta, bread, pastries, beans/lentils (temporarily if SIBO symptoms), and refined carbs	Klebsiella grows well on starch (it makes pullulanase to break it down); reducing starch lowered Klebsiella from ~30,000/g to ~700/g in a trial
	Avoid added sugars & HFCS: limit soda, candy, pastries, sugary cereals	Simple sugars feed pathogenic bacteria and worsen dysbiosis
Feed Bifido & Lactobacillus	High diverse fiber from non-starchy veggies: leafy greens, broccoli, cabbage, zucchini, cucumbers, bell peppers, mushrooms, asparagus (if tolerated), artichokes	Fiber → short-chain fatty acids (SCFAs) that protect against pathogens and support beneficial bacteria
	Low-FODMAP prebiotics if SIBO symptoms: start with psyllium husk, small amounts of oats, berries, citrus, carrots, green bananas	Supports good bacteria without excessive fermentation; high-FODMAP prebiotics (garlic/onion/jerusalem artichoke) can worsen SIBO initially
	Fermented foods daily: unsweetened yogurt/kefir (lactose-free if needed), sauerkraut, kimchi, kombucha, miso	Increases microbiome diversity and lowers inflammation; provides live Lactobacillus/Bifidobacterium
Anti-inflammatory support	Omega-3s (fatty fish 2–3×/week or fish oil), polyphenols (berries, green tea, olive oil, dark cocoa), white meat/fish/eggs, avocado, nuts, seeds	Reduces gut inflammation and supports barrier integrity

Supplement strategy

Supplement	Rationale	Typical considerations

Supplement	Rationale	Typical considerations
Bifidobacterium probiotic (e.g., B. longum, B. breve, B. infantis)	Directly increases low Bifidobacterium; B. longum showed protection against Klebsiella in studies	Look for multi-strain with Bifido; 1–10 billion CFU/day initially, may go higher if needed
Lactobacillus probiotic (L. rhamnosus, L. plantarum, L. acidophilus, L. helveticus)	These strains inhibit Klebsiella via lactic acid/bacteriocins and compete for adhesion sites	Multi-strain Lactobacillus + Bifidobacterium is often best
Saccharomyces boulardii (beneficial yeast)	Helps discourage Klebsiella, reduces inflammation, supports SIBO treatment	250–500 mg 1–2×/day; take separately from bacterial probiotics
Psyllium husk (soluble fiber)	Gentle prebiotic that feeds good bacteria and produces SCFAs; shown to reduce Klebsiella dissemination	Start 2.5–5 g/day, increase slowly with plenty of water
Optional: herbal antimicrobials (berberine, oregano oil, neem, garlic extract)	Clinicians report success reducing Klebsiella/Enterobacter overgrowth; berberine/oil have broad antimicrobial activity	Use under professional guidance only; cycle (e.g., 2–4 weeks), then re-test. Avoid long-term use.
E. coli probiotic (Mutaflor/Symbioflor)	Contains specific E. coli Nissle strain to replenish low E. coli; used clinically for gut balance	Discuss with clinician; some protocols pulse then maintain

Prescription

No specific “best” prescription drug is indicated purely by this microbiome pattern; if treatment is needed, clinicians usually treat it as small intestinal/colonic bacterial overgrowth with short courses of narrowest‑possible antibiotics guided by symptoms, cultures, and resistance patterns, plus a prescription‐grade probiotic such as E. coli Nissle in some cases.

OpenEvidence

Dietary Modifications

A Mediterranean-style dietary pattern rich in fruits, vegetables, whole grains, legumes, nuts, olive oil, and fish is the best-supported overall framework. This pattern is associated with favorable gut microbial profiles, increased fiber-degrading beneficial bacteria (including Faecalibacterium and Ruminococcus), and lower subclinical intestinal inflammation. [1-3] Ultraprocessed foods should be minimized, as they are linked to dysbiosis. [1]

Key dietary components to emphasize:

• Prebiotic fibers — particularly fructans (inulin, FOS) and galacto-oligosaccharides (GOS) — have the strongest evidence for selectively increasing Bifidobacterium and Lactobacillus abundance. A meta-analysis of 64 RCTs (n=2099) demonstrated significantly higher Bifidobacterium (SMD 0.64, P<0.00001) and Lactobacillus (SMD 0.22, P=0.02) with dietary fiber interventions, with fructans and GOS showing the greatest effect. Food sources include chicory root, garlic, onions, leeks, asparagus, bananas, and Jerusalem artichokes. [4]
• Resistant starch (found in cooked-and-cooled potatoes/rice, green bananas, legumes, and whole grains) acts as a fermentable substrate that promotes Bifidobacterium and Lactobacillus growth and increases butyrate production. [5-6]
• Polyphenol-rich foods — berries, apples, grapes, green tea, dark chocolate, and extra-virgin olive oil — may help suppress Enterobacteriaceae (including Klebsiella). In vivo studies show resveratrol, phloretin (apples/strawberries), and other polyphenols can reduce Enterobacteriaceae levels while promoting beneficial bacteria, though most data are from animal models. [7-8]
• Lactose restriction may be worth considering given the Enterococcus overgrowth. A recent study in a transplant unit found that implementing a lactose-free diet significantly reduced VRE carriage (16% → 3.6%), consistent with evidence that lactose can fuel Enterococcus growth. [9]
• Fermented foods — yogurt, kefir, kimchi, sauerkraut, miso — provide live Lactobacillus and Bifidobacterium species that can transiently colonize the gut and modulate the microbiome. A high-fermented-food diet has been associated with increased microbial diversity and decreased inflammatory markers. [10-12]

Supplement Recommendations

• Probiotic supplementation with multi-strain formulations containing Bifidobacterium (B. longum, B. lactis, B. bifidum) and Lactobacillus (L. rhamnosus, L. acidophilus, L. plantarum, L. paracasei) species is the most direct approach to replenishing depleted populations. L. paracasei CNCM I-3689 has specifically been shown to reduce Enterococcus persistence and promote Bacteroidetes recovery in a dysbiosis model. Probiotics suppress pathogens through competitive exclusion, bacteriocin production, pH lowering, and gut barrier enhancement. [13-17]
• Prebiotic supplements — inulin-type fructans (ITF) and arabinoxylan-oligosaccharides (AXOS) — selectively stimulate Bifidobacterium growth and promote butyrate production through cross-feeding with butyrate-producing bacteria. A synbiotic approach (combining prebiotics with probiotics) may enhance probiotic colonization and provide synergistic benefits. [14][18-19]
• Butyrate supplementation or butyrate-promoting strategies may help strengthen the gut barrier and create an environment less favorable to facultative anaerobes like Klebsiella and Enterococcus, as butyrate lowers colonic pH and supports epithelial integrity. [16][18]

Prescription

It is important to emphasize that no prescription drugs are FDA-approved specifically for treating gut dysbiosis as identified by stool microbiome testing. The clinical significance of specific bacterial abundance thresholds on commercial microbiome panels remains debated, and treatment should be guided by symptoms and clinical context rather than microbiome test results alone. That said, several prescription medications can be considered based on the specific dysbiotic pattern described:

Rifaximin (Xifaxan) — The Most Relevant Prescription Option

Rifaximin 550 mg TID for 14 days is the prescription drug with the strongest rationale for this dysbiotic profile. Unlike conventional antibiotics, rifaximin has unique “eubiotic” properties — it selectively increases Lactobacillus and Bifidobacterium abundance while suppressing pathobionts, without significantly disrupting overall microbial diversity. [1-3] Metagenomic analyses have confirmed a significant increase in Lactobacilli persisting in the short term after rifaximin treatment, independent of the underlying disease. [2] Rifaximin also reduces bacterial virulence and translocation, and has anti-inflammatory effects via PXR nuclear receptor activation. [4] The ACG recommends rifaximin as first-line therapy for SIBO at 550 mg TID for 14 days, with an overall ~70% eradication rate. [5-8] However, SIBO is not an FDA-approved indication, and insurance coverage may be challenging. [5]

E. coli Nissle 1917 (Mutaflor)

For the specific finding of depleted E. coli, E. coli Nissle 1917 (marketed as Mutaflor) is a prescription-grade probiotic available in some countries (Germany, Canada) but not FDA-approved in the United States. It is the only probiotic recommended in ECCO guidelines as an effective alternative to mesalazine for maintenance of remission in ulcerative colitis. [9] EcN stimulates human β-defensin 2 production, protects the mucosal barrier, and has demonstrated antagonistic effects against Salmonella, Shigella, and other invasive commensals. [10-11] It directly addresses the depleted commensal E. coli niche.

Antibiotics Targeting Klebsiella/Enterobacter Overgrowth

If the Klebsiella/Enterobacter overgrowth is causing clinical infection (not merely colonization), targeted antibiotics may be warranted:

• For susceptible Enterobacterales: fluoroquinolones (ciprofloxacin), TMP-SMX, or amoxicillin-clavulanate based on susceptibility testing [5-6]
• For AmpC-producing Enterobacter: cefepime is recommended by IDSA guidelines [12-13]
• For ESBL-producing organisms: carbapenems (meropenem, imipenem) are preferred for serious infections [14-15]

However, broad-spectrum antibiotics for asymptomatic colonization are not recommended, as they would likely worsen the underlying dysbiosis. [6]

Antibiotics Targeting Enterococcus Overgrowth

Similarly, Enterococcus overgrowth in the absence of clinical infection does not typically warrant antibiotic treatment. If treatment is needed:

• Ampicillin/amoxicillin is preferred when susceptible [16]
• For VRE: linezolid or daptomycin have demonstrated clinical efficacy [16]
• A novel decolonization approach combining bowel preparation with polyethylene glycol, oral linezolid + non-absorbable daptomycin, followed by Lactobacillus rhamnosus GG to maintain colonization resistance, has shown success in clearing VRE carriage in a small case series. [17]

Deep Seek

 Dietary strategy (core principles)

✅ Emphasize

• Low-fermentation, low-starch approach initially:
  Klebsiella and Enterobacter thrive on resistant starch and certain fibers, producing gas, LPS, and histamine. A temporary low-FODMAP + low-starch phase (2–4 weeks) helps reduce their load.
• Prebiotics with caution:
  Instead of high-FODMAP fibers (inulin, chicory, large amounts of legumes), use acacia fiber or PHGG (partially hydrolyzed guar gum) in small, increasing doses—these favor Bifidobacteria without overly feeding Klebsiella.
• Polyphenol-rich foods:
  Berries, green tea, pomegranate, dark chocolate (>70%), and olive oil. Polyphenols inhibit Enterococcus and Klebsiella while promoting Lactobacillus.
• Animal protein + low-carb vegetables:
  Grass-fed meat, eggs, fish, and leafy greens—limited fermentation in the colon.
• Fermented foods if tolerated:
  Small amounts of sauerkraut, kimchi, or kefir (start with 1 tbsp) can reintroduce beneficial strains, but watch for histamine reactions due to possible gut permeability.

❌ Avoid or restrict

• High-starch foods: Potatoes, corn, wheat, rice, oats, bread, pasta—especially if cooled/reheated (resistant starch).
• High-sugar fruits and sweeteners: Fructose and sucrose feed Klebsiella and Enterococcus.
• Lactose-rich dairy (unless fermented and low-lactose like hard cheese or lactose-free yogurt).
• Processed foods and emulsifiers (polysorbate 80, carboxymethylcellulose) – promote Enterobacter and degrade mucus.

 Targeted supplements

Phase 1: Reduce overgrowth (first 4–6 weeks)

Supplement	Rationale
Berberine (500 mg 2–3x/day)	Broad antimicrobial against Klebsiella, Enterobacter, Enterococcus; also reduces gut inflammation.
Oregano oil (enteric-coated)	Strong against Enterococcus and Klebsiella; use 2–4 weeks only, then stop.
Bismuth subnitrate or subcitrate (optional, if hydrogen sulfide symptoms)	Binds to overgrown bacteria, reduces biofilm.

Phase 2: Rebuild beneficial bacteria (after reducing pathogens)

Supplement	Rationale
Probiotics – choose non-lactose, low-histamine strains: Lactobacillus plantarum, L. rhamnosus GG, Bifidobacterium lactis (start low dose). Avoid high-dose L. acidophilus initially—can sometimes paradoxically feed Enterococcus.
Spore-based probiotics (Bacillus coagulans, B. clausii) – resist Klebsiella biofilm and help restore butyrate.
Fecal microbiota transplantation? – only for refractory cases, but diet+supplements first.

Phase 3: Support gut barrier and immunity

Supplement	Rationale
Zinc carnosine (75–150 mg/day) – restores tight junctions damaged by Klebsiella.
Colostrum or immunoglobulin G (IgG) – binds LPS from Enterobacter and helps clear pathobionts.
Butyrate (tributyrin or resistant starch only after pathogens reduced) – feeds colonocytes, suppresses Enterococcus.

---

3. Special considerations

• Low E. coli means reduced production of colicins (natural antimicrobials against Klebsiella). In some contexts, supplementing a non-pathogenic E. coli strain (like E. coli Nissle 1917, Mutaflor) can be beneficial, but use only after pathogen load is reduced, and under medical guidance (risk of UTI in susceptible patients).
• Low Bifidobacterium and Lactobacillus → consider human milk oligosaccharides (HMOs) like 2’FL (1–2 g/day) – very specific prebiotic for Bifidobacteria, minimally used by Klebsiella.
• Biotin and B vitamins – overgrowth of Klebsiella/Enterococcus consumes biotin; supplementation may help host metabolism.

Prescription

💊 1. Treating the Overgrowth: A Targeted Approach

Prescription antibiotics are only indicated if the overgrowth of Klebsiella, Enterobacter, or Enterococcus is causing a confirmed active infection (e.g., urinary tract infection, pneumonia, bacteremia) or a diagnosed condition like Small Intestinal Bacterial Overgrowth (SIBO).

If treatment is necessary, the choice is not one-size-fits-all. Because these bacteria have high rates of antibiotic resistance, therapy must be guided by antibiotic susceptibility testing (culture and sensitivity) .

Overgrown Organism	Condition	Potential Prescription Approach
Klebsiella / Enterobacter	Confirmed SIBO or specific infection	Rifaximin is a non-absorbable antibiotic often used for SIBO, but studies show its effectiveness varies significantly. It inhibits only about 43.6% of Klebsiella and 34.8% of Enterobacter strains . For systemic infections, other antibiotics like third-generation cephalosporins, carbapenems, or fluoroquinolones may be used, but this depends entirely on resistance testing .
Enterococcus	Confirmed infection (e.g., UTI, bacteremia)	Ampicillin or amoxicillin are the agents of choice for susceptible strains . High-level resistance is common, especially with E. faecium, often requiring infectious disease consultation for drugs like linezolid or daptomycin .

Important note on antibiotics: Using systemic antibiotics to target the bacteria in the gut lumen is generally avoided. It will likely worsen the underlying dysbiosis by further reducing beneficial Bifidobacterium and Lactobacillus, which are already low .

🔄 2. Restoring the Microbiome: Fecal Microbiota Transplantation (FMT)

Rather than using a drug to kill the “bad” bacteria, a more logical approach to restoring the balance of E. coli, Bifidobacterium, and Lactobacillus is Fecal Microbiota Transplantation (FMT).

FMT involves infusing healthy donor stool into the patient’s intestine to directly restore a diverse and balanced microbiome. However, its use is currently restricted by clinical guidelines:

• Approved Use: FMT is strongly recommended by the American Gastroenterological Association (AGA) for patients with recurrent Clostridioides difficile infection (CDI) .
• Off-Label and Experimental: For the specific pattern of dysbiosis you described (without a CDI diagnosis), FMT is not recommended outside of clinical trials . While Chinese expert consensus suggests it may be explored for severe gut dysbiosis, this is not a standard or approved practice in most other regions .

🧫 A Note on E. coli Restoration

You noted that E. coli is 50% below normal. While E. coli is often thought of as a pathogen, certain strains are a normal part of a healthy gut microbiome. A specific probiotic called E. coli Nissle 1917 has been studied for its ability to support gut health. However, this is generally available as a medical food or supplement, not a standard prescription drug, and should only be used under the guidance of a physician. This is not a standard treatment in most clinical settings.

ChatGPT

Dietary changes that are often considered

The most evidence-supported approach is usually to encourage beneficial bacteria through diet rather than trying to eliminate specific organisms.

Increase prebiotic fibers gradually

These preferentially support Bifidobacterium and other beneficial microbes:

• Onions
• Garlic
• Leeks
• Asparagus
• Jerusalem artichokes
• Oats
• Barley
• Legumes (if tolerated)
• Green bananas
• Cooked-and-cooled potatoes or rice (resistant starch)

If bloating is severe, introduce these slowly.

Increase diverse plant intake

Studies consistently associate greater microbial diversity with consuming a wide variety of plant foods.

A common target is:

• 25–40 g/day fiber (depending on tolerance and medical conditions)
• 20–30 different plant foods per week

Consider fermented foods

If tolerated:

• Yogurt with live cultures
• Kefir
• Sauerkraut
• Kimchi
• Miso

These may help increase exposure to beneficial microbes, though they do not necessarily permanently colonize the gut.

Limit factors associated with Enterobacteriaceae overgrowth

Klebsiella and Enterobacter belong to the family Enterobacteriaceae.

Potentially helpful:

• Reduce ultra-processed foods.
• Reduce excessive refined sugars.
• Moderate alcohol intake.
• Ensure adequate fiber.

Evidence for aggressively restricting carbohydrates specifically to suppress these organisms is limited.

---

Supplements that may be discussed with a clinician

Bifidobacterium-containing probiotics

Given low Bifidobacterium, strains commonly studied include:

• Bifidobacterium longum
• Bifidobacterium lactis
• Bifidobacterium bifidum

Lactobacillus-containing probiotics

Given low Lactobacillus, strains commonly studied include:

• Lactobacillus rhamnosus GG
• Lactobacillus plantarum
• Lactobacillus reuteri

Prebiotics

Often more effective at increasing resident beneficial bacteria than probiotics alone:

• Inulin
• FOS (fructooligosaccharides)
• GOS (galactooligosaccharides)
• Resistant starch

GOS in particular is frequently associated with increases in Bifidobacterium.

Partially hydrolyzed guar gum (PHGG)

PHGG has some evidence for:

• Increasing beneficial bacteria
• Improving constipation and IBS symptoms in some people
• Being better tolerated than some other fibers

---

Things to be cautious about

Antimicrobial supplements

Products marketed to “kill Klebsiella” or “eradicate Enterococcus” (oregano oil, berberine, etc.) can sometimes further disrupt the microbiome. Whether they are appropriate depends on the clinical situation and should not be based solely on a stool microbiome report.

Very restrictive diets

Long-term low-fiber or highly restrictive diets may further reduce Bifidobacterium and Lactobacillus populations.

Prescription

There is no standard prescription drug regimen that should be given solely because a microbiome report shows low E. coli, low Bifidobacterium, low Lactobacillus, and elevated Klebsiella/Enterobacter and Enterococcus.

In current clinical practice, doctors generally treat diseases and symptoms, not microbiome composition alone. A stool microbiome test cannot reliably determine which prescription drug is appropriate.

Summary

First unfortunate fact is that most retail and many clinical microbiome tests do not accurately measure E.Coli.In my own experience, the E.Coli probiotics cited several times above were very effective (with the warning that it can cause a major die off)

Concerning antibiotics, the Jadin approach of rotating with just one course per month is recommended.